Home » BIO ENDORSES NOMINATION OF VON ESCHENBACH TO HEAD FDA
BIO ENDORSES NOMINATION OF VON ESCHENBACH TO HEAD FDA
Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), released a statement encouraging the U.S. Senate to swiftly confirm Dr. Andrew von Eschenbach as commissioner of the Food and Drug Administration (FDA).
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May